المؤلفون: Lorente D; Servicio de Oncología Médica, Hospital Provincial de Castellón, Castellón de la Plana, Spain; Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre, Madrid, Spain. Electronic address: dlorenteestelles@seom.org., Castro E; Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre, Madrid, Spain; Genitourinary Cancer Translational Research Group, The Institute of Biomedical Research in Málaga, Málaga, Spain; IBIMA, UGCI Oncología Médica, Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Málaga, Spain., Lozano R; Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre, Madrid, Spain; Genitourinary Cancer Translational Research Group, The Institute of Biomedical Research in Málaga, Málaga, Spain., Puente J; Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain., Romero-Laorden N; Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre, Madrid, Spain; Hospital Universitario La Princesa, Madrid, Spain., Rodríguez-Vida A; Hospital del Mar, Barcelona, Spain., Lainez N; Complejo Hospitalario de Navarra, Pamplona, Spain., Villatoro R; Hospital Universitario Costa del Sol, Marbella, Spain., Llácer C; Genitourinary Cancer Translational Research Group, The Institute of Biomedical Research in Málaga, Málaga, Spain; IBIMA, UGCI Oncología Médica, Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Málaga, Spain., Cattrini C; Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre, Madrid, Spain; Academic Unit of Medical Oncology, IRCCS San Martino Polyclinic Hospital, Genoa, Italy., Hernández A; Onkologikoa-Instituto Oncológico, Donostia, Spain., Domenech M; Fundació Althaia Manresa, Manresa, Spain., Zambrana F; Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Spain., Almagro E; Hospital Universitario Quirón, Madrid, Spain., Luque R; Complejo Hospitalario Universitario de Granada, Granada, Spain., Martinez E; Hospital Universitario de Jaén, Jaén, Spain., López-Campos F; Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre, Madrid, Spain; Hospital Universitario Ramón y Cajal, Madrid, Spain., Gonzalez B; Hospital de Son Llatzer, Palma de Mallorca, Spain., Méndez-Vidal MJ; Hospital Universitario Reina Sofía, Córdoba, Spain., Medina A; Centro Oncológico de Galicia, A Coruña, Spain., Piulats JM; Institut Catalá d'Oncologia, Hospitalet de Llobregat, Spain., Olmos D; Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre, Madrid, Spain; Genitourinary Cancer Translational Research Group, The Institute of Biomedical Research in Málaga, Málaga, Spain.

مؤلفون مشاركون: PROREPAIR-B Study Investigators

المصدر: European urology [Eur Urol] 2020 Jun; Vol. 77 (6), pp. 763-766. Date of Electronic Publication: 2020 Mar 03.

نوع المنشور: Letter; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Neoplasms, Castration-Resistant/*mortality, Humans ; Male ; Neoplasm Metastasis ; Progression-Free Survival ; Prostatic Neoplasms, Castration-Resistant/pathology ; Survival Rate